---
$id: https://graph.org.ai/products/commodity/51101911
$type: Product
source: UNSPSC
code: "51101911"
title: "Halofantrine"
class: "51101900"
classTitle: "Antiprotozoals"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Halofantrine

**UNSPSC Code**: 51101911
**Class**: [Antiprotozoals](Antiprotozoals.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimalarial agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q2OS4303HZ. European Medicines Agency schedules Halofantrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07998MIG. Halofantrine generally arises in the molecular formula C26H30CL2F3NO. The term HALOFANTRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, no. 10 1980, list 20.) HALOFANTRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule halofantrine under HS 29221980 and SITC 51461. As of Q4 2014, HALOFANTRINE remains the US FDA Preferred Term for this commodity. Halofantrine bears US NLM identifiers UMLS ID C0120726 and NCI Concept Code C65838. SMILES: CLC1C2CC(C(O)CCN(CCCC)CCCC)C3C(C2CC(CL)C1)CC(CC3)C(F)(F)F.

